CHAYA GEWANTER: Open Payments
NPI 1629769062 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 17 payments from 8 companies in 2025. Trend: 2023 $233 · 2024 $40 · 2025 $593
Food & beverage: $593
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 1 | $160 |
| Insulet Corporation | 3 | $145 |
| Xeris Pharmaceuticals, Inc. | 6 | $128 |
| Renalytix AI, Inc. | 2 | $49 |
| Tandem Diabetes Care, Inc. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: DEXCOM G7 GSS (161), Omnipod, GVOKE HYPOPEN, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT, t:slim X2 Insulin Pump with Control-IQ, VPRIV, FARXIGA, RECORLEV.
Industry payments across NY — which companies pay providers there.
